Skip to main content
SpringerLink
Log in

Positronenemissionstomographie(PET)-geleitete Behandlung des Hodgkin-Lymphoms im frühen Stadium mit günstigen Risikofaktoren: Endresultate der internationalen randomisierten Phase-III-HD16-Studie der Deutschen Hodgkin-Studiengruppe

Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international randomized phase III HD16 trial conducted by the German Hodgkin Study Group

  • Literatur kommentiert
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Bröckelmann PJ, Angelopoulou MK, Vassilakopoulos TP (2016) Prognosticfactors in Hodgkin lymphoma. Semin Hematol 53:155–164

    Article  Google Scholar 

  2. Shanbhag S, Ambinder RF (2018) Hodgkin lymphoma: a review and update on recent progress. CA Cancer J Clin 68:116–132

    Article  Google Scholar 

  3. Engert A, Raemaekers J (2016) Treatment of early-stage Hodgkin lymphoma. Semin Hematol 53:165–170

    Article  Google Scholar 

  4. Franklin J, Eichenauer DA, Becker I et al (2017) Optimisation of chemotherapy and radiotherapy for untreated Hodgkin lymphoma patients with respect to second malignant neoplasms, overall and progression-free survival: individual participant data analysis. Cochrane Database Syst Rev 13;9:CD8814

    Google Scholar 

  5. Bröckelmann PJ, Sasse S, Engert A (2018) Balancing risk and benefit in early-stage classical Hodgkin lymphoma. Blood 131:1666–1678

    Article  Google Scholar 

  6. Straus DJ, Jung SH, Pitcher B et al (2018) CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET. Blood 132:1013–1021

    Article  CAS  Google Scholar 

  7. Fuchs M, Goergen H, Kobe C et al (2019) Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group. J Clin Oncol 37:2835–2845

    Article  Google Scholar 

  8. Adams HJA, Kwee TC (2017) An evidence-based review on the value of interim FDG-PET in assessing response to therapy in lymphoma. Semin Oncol 44:404–419

    Article  Google Scholar 

  9. Hutchings M (2018) Improvements in imaging of Hodgkin lymphoma: positron emission tomography. Cancer J 24:215–222

    Article  Google Scholar 

  10. Radford J, Illidge T, Counsell N et al (2015) Results of a trial of PET-directed therapy for early-stage Hodgkin’s lymphoma. N Engl J Med 372:1598–1607

    Article  CAS  Google Scholar 

  11. Andre MPE, Girinsky T, Federico M et al (2017) Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: Final results of the randomized EORTC/LYSA/FIL H10 trial. J Clin Oncol 35(10):1786–1794

    Article  CAS  Google Scholar 

  12. Bröckelmann PJ, McMullen S, Wilson JB et al (2019) Patient and physician preferences for first-line treatment of classical Hodgkin lymphoma in Germany, France and the United Kingdom. Br J Haematol 184:202–214

    Article  Google Scholar 

  13. Lagerlöf I, Holte H, Glimelius I et al (2019) No excess long-term mortality in stage I–IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy. Br J Haematol. https://doi.org/10.1111/bjh.16232

    Article  PubMed  Google Scholar 

  14. Specht L (2018) Radiotherapy for Hodgkin lymphoma: reducing toxicity while maintaining efficacy. Cancer J 24:237–243

    Article  Google Scholar 

  15. Edvardsson A, Kügele M, Alkner S et al (2019) Comparative treatment planning study for mediastinal Hodgkin’s lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy. Acta Oncol 58:95–104

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dept. of Oncology and Palliative Medicine, Nordland Hospital Trust, P.O. Box 1480, 8092, Bodø, Norwegen

    Carsten Nieder

Authors
  1. Carsten Nieder
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Carsten Nieder.

Ethics declarations

Interessenkonflikt

C. Nieder gibt an, dass kein Interessenkonflikt besteht.

Additional information

Originalpublikation

Fuchs M, Goergen H, Kobe C et al (2019) Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: Final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group. J Clin Oncol 37:2835–2845

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nieder, C. Positronenemissionstomographie(PET)-geleitete Behandlung des Hodgkin-Lymphoms im frühen Stadium mit günstigen Risikofaktoren: Endresultate der internationalen randomisierten Phase-III-HD16-Studie der Deutschen Hodgkin-Studiengruppe. Strahlenther Onkol 196, 414–415 (2020). https://doi.org/10.1007/s00066-020-01593-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-020-01593-0

Search

Navigation